Himalaya Nutravedics IPO Day 1: Subscribed 0.05x; NII bHNI leads at 0.18x
- Himalaya Nutravedics IPO subscribed 0.05x on Day 1.
- NII (bHNI) led demand at 0.18x, while Retail stood at 0.07x.
- QIB subscription remained flat at 0.00x.
*this image is generated using AI for illustrative purposes only.
Himalaya Nutravedics IPO subscribed 0.05x on Day 1. Non-Institutional Buyers (sHNI) led the demand at 0.12x, while Retail and bHNI categories saw muted interest.
Subscription Status
The public issue opened for subscription on September 22, 2026. By the end of Day 1, the issue was subscribed 0.05 times. The strongest demand came from the Non-Institutional Investors (sHNI) category.
| Day | Date | QIB | NII (bHNI) | NII (sHNI) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 22-09-2026 | 0.00x | 0.18x | 0.00x | 0.07x | 0.05x |
Intra-day Timeline
The subscription data remained static throughout the trading hours on Day 1.
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 11:15 | 0.00x | 0.12x | 0.05x | 0.03x |
| 12:15 | 0.00x | 0.18x | 0.07x | 0.05x |
Momentum highlights (day-open vs latest)
- QIB: 0.00x → 0.00x (Δ +0.00x)
- NII (bHNI): 0.12x → 0.18x (Δ +0.06x (+50.0%))
- Retail: 0.05x → 0.07x (Δ +0.02x (+40.0%))
- Total: 0.03x → 0.05x (Δ +0.02x (+66.7%))
Standout intraday moves (>= 3% jump today):
- NII (bHNI) jumped +50.0% today (from 0.12x to 0.18x)
- Retail jumped +40.0% today (from 0.05x to 0.07x)
- Total jumped +66.7% today (from 0.03x to 0.05x)
Category-wise Breakdown
- Qualified Institutional Buyers (QIB): 0.00x
- Non-Institutional Buyers (bHNI): 0.18x
- Non-Institutional Buyers (sHNI): 0.00x
- Retail: 0.07x
- Employees: 0.00x
Offer Details
- Company: Himalaya Nutravedics
- Price Band: ₹100.00000 - ₹106.00000
- Issue Size: 240000 - 500000
- Minimum Bid Quantity: 2400
- Open Date: 2026-09-22
- Close Date: 2026-09-24
About the Company
Himalaya Nutravedics India Limited is a Hyderabad-based manufacturer, marketer, and distributor of Ayurvedic and Nutraceutical formulations. Operating through a hybrid model, it produces own-brand products and handles third-party contract manufacturing. The company operates a single WHO-GMP, ISO 9001:2015, and ISO 22000:2018 certified facility in Cherlapally, Hyderabad. Revenue from operations grew from ₹1,442.56 lakhs in FY2024 to ₹4,306.75 lakhs in FY2026.
Financial Highlights
| Period | Revenue from Operations (₹ Cr) | Total Expenses (₹ Cr) | Profit for the Period (₹ Cr) |
|---|---|---|---|
| FY2026 | 43.07 | 35.64 | 7.39 |
| FY2025 | 21.00 | 18.75 | 2.23 |
| FY2024 | 14.43 | 13.83 | 0.43 |
Objects of the Issue
- Funding Working Capital Requirements: ₹13.75 crore
- Investment in Branding, Digital Marketing and Sales Expansion: ₹7.50 crore
- General Corporate Purposes: Balance proceeds
Risk Factors
- High Customer Concentration Risk: Top 10 customers accounted for 81.24% of revenue in FY2026.
- Negative Cash Flows: Operating cash flows were negative in FY2026, FY2025, and FY2024.
- Expiry of Tax Benefits: Tax holiday under Section 80-IAC expires post-FY2027, impacting net margins.
What's Next
The issue closes on September 24, 2026. Allotment will be finalized on September 25, 2026, with listing scheduled for September 29, 2026.
Will the lack of interest from Qualified Institutional Buyers (QIBs) on Day 1 trigger a downward revision in the IPO price band?
Can the issue achieve full subscription by the closing date on September 24 given the static intra-day momentum and muted retail demand?
How will the expiry of tax benefits under Section 80-IAC post-FY2027 impact the company's future net margins and investor valuation?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
